Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2013 Sep 9:6:362.
doi: 10.1186/1756-0500-6-362.

Tyrosinemia type 1: a rare and forgotten cause of reversible hypertrophic cardiomyopathy in infancy

Sarar Mohamed  1 , Mohammed A Kambal, Nasir A Al Jurayyan, Abdulrahman Al-Nemri, Amir Babiker, Rana Hasanato, Abdullah S Al-Jarallah
Affiliations
Case Reports

Tyrosinemia type 1: a rare and forgotten cause of reversible hypertrophic cardiomyopathy in infancy

Sarar Mohamed et al. BMC Res Notes. .

Abstract

Background: Tyrosinemia type 1 (TT1) is an autosomal recessive disorder caused by deficiency of the enzyme fumarylacetoacetate hydrolase (FAH). TT1 usually presents in infancy with features suggestive of liver disease or with sepsis-like symptoms.

Case presentation: We report two Saudi siblings with TT1. Case 1 was a male infant who presented at 2 months old with fever, vomiting and refusal of feeding. Examination revealed a sick-looking infant with signs of severe dehydration and hypovolemic shock. He was jaundiced, and had hepatomegaly and elevated liver enzymes. Echocardiography was performed in light of a lack of response to inotropes, and revealed biventricular and interventricular septal hypertrophies. The ventricular ejection fraction was 65%. Urine organic acid analysis showed elevated succinylacetone, consistent with a diagnosis of TT1. An FAH gene study identified a c.1 A > G homozygous mutation. This patient responded well to intensive cardiorespiratory therapy, tyrosine-free formula, and oral 2-nitro-4- trifluoromethylbenzyl 1, 3 cyclohexanedione (NTBC). Echocardiographic findings reverted to normal after 4 weeks. Case 2 was the younger brother of Case 1, and was born 6 months after his brother had been confirmed with tyrosinemia. Pregnancy and delivery were uneventful. Serum amino acid and organic acid analyses 4 days after birth confirmed tyrosinemia. DNA analysis identified a c.1 A > G homozygous mutation, as in his brother. Echocardiography was normal. Special formula and NTBC were commenced on day 7 of life. The infant remained asymptomatic after 9 months of follow-up.

Conclusions: These cases highlight TT1 as a treatable cause of cardiomyopathy in children. It also supports the idea that early diagnosis and treatment may prevent the development of cardiomyopathy associated with tyrosinemia.

PubMed Disclaimer

Figures

Figure 1
Figure 1
M mode measurements revealing an interventricular septum size of 0.59 cm before treatment.
Figure 2
Figure 2
M mode measurements revealing an interventricular septum size of 0.42 cm after treatment.
Figure 3
Figure 3
Long axis view revealing improvement in interventricular septum thickness with treatment.
See this image and copyright information in PMC

References

    1. Mitchell GA, Grompe M, Lambert M, Tanguay RM. In: Hypertyrosinemia : the metabolic and molecular bases of inherited disease. 5. Scriver CR, Beaudet A, Sly WS, Valle D, editor. New York: McGraw Hill; 2001. pp. 1777–1806.
    1. Rashed MS, Al-Ahaidib LY, Al-Dirbashi OY. Tandem mass spectrometric assay of succinylacetone in urine for diagnosis of hepatorenaltyrosinemia. Anal Biochem. 2005;339:310–317. doi: 10.1016/j.ab.2005.01.014. - DOI - PubMed
    1. Rashad M, Nassar C. Tyrosinemia type 1: a case report. Sudan J Pediatr. 2011;11(1):64–67. - PMC - PubMed
    1. Wilkinson J, Sleeper L, Alvarez J, Bublik N, Lipshultz S. The pediatric cardiomyopathy registry: 1995–2007. ProgPediatrCardiol. 2008;25(1):31–36. - PMC - PubMed
    1. Nugent AW, Daubeney PEF, Chondros P, Carlin JB, Cheung M, Wilkinson LC, Davis AM, Kahler SG, Chow CW, Wilkinson JL, Weintraub RG. National Australian childhood cardiomyopathy study.: the epidemiology of childhood cardiomyopathy in Australia. N Engl J Med. 2003;348(17):1639–1646. doi: 10.1056/NEJMoa021737. - DOI - PubMed

Publication types

MeSH terms

LinkOut - more resources